Colistin Combined With Tigecycline: A Promising Alternative Strategy to Combat Escherichia coli Harboring bla(NDM–)(5) and mcr-1

Infections due to carbapenem-resistant NDM-producing Escherichia coli represent a major therapeutic challenge, especially in situations of pre-existing colistin resistance. The aim of this study was to investigate combinatorial pharmacodynamics of colistin and tigecycline against E. coli harboring b...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Microbiol
Egile Nagusiak: Zhou, Yu-Feng, Liu, Ping, Zhang, Chuan-Jian, Liao, Xiao-Ping, Sun, Jian, Liu, Ya-Hong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2020
Gaiak:
Microbiology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6960404/
https://ncbi.nlm.nih.gov/pubmed/31969868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2019.02957
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak